The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

SITC 2021 | Promising future of immunotherapy for solid tumors

Name: Promising future of immunotherapy for solid tumors
Uploaded: 2021-11-12T00:00:00Z
Duration: 54 s
Description: Julian Molina, MD, PhD, Mayo Clinic, Rochester, MN, emphasises the promising future of immunotherapy for solid tumors, especially melanoma and lung cancer. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

Julian Molina • 12 Nov 2021

SITC 2021

Lung Cancer Melanoma Skin Cancer

Julian Molina, MD, PhD, Mayo Clinic, Rochester, MN, emphasises the promising future of immunotherapy for solid tumors, especially melanoma and lung cancer. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.